(2S,3S)-2-[(2S)-2-(4-tert-butoxybenzyl)-9-nitro-3-oxo-1,2,3,5-tetrahydrobenzo[1,4]diazepin-4-yl]-3-metylpentanoic acid | 857041-09-9

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: (2S,3S)-2-[(2S)-2-(4-tert-butoxybenzyl)-9-nitro-3-oxo-1,2,3,5-tetrahydrobenzo[1,4]diazepin-4-yl]-3-metylpentanoic acid
• 英文别名: (2S,3S)-3-methyl-2-[(2S)-2-[[4-[(2-methylpropan-2-yl)oxy]phenyl]methyl]-9-nitro-3-oxo-2,5-dihydro-1H-1,4-benzodiazepin-4-yl]pentanoic acid
• CAS: 857041-09-9
• 化学式: C₂₆H₃₃N₃O₆
• 分子量: 483.565
• InChiKey: SXAXLVBRNFELKT-GRWTVWFQSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.1
• 重原子数：
  35
• 可旋转键数：
  8
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.46
• 拓扑面积：
  125
• 氢给体数：
  2
• 氢受体数：
  7

反应信息

• 作为反应物：
  描述：

  (2S,3S)-2-[(2S)-2-(4-tert-butoxybenzyl)-9-nitro-3-oxo-1,2,3,5-tetrahydrobenzo[1,4]diazepin-4-yl]-3-metylpentanoic acid 在 palladium on activated charcoal ammonium formate 作用下， 以 甲醇 为溶剂， 反应 2.5h， 生成
  参考文献：
  名称：

  New Selective AT₂ Receptor Ligands Encompassing a γ-Turn Mimetic Replacing the Amino Acid Residues 4−5 of Angiotensin II Act as Agonists

  摘要：

  New benzodiazepine-based gamma-turn mimetics with one or two amino acid side chains were synthesized. The gamma-turn mimetics were incorporated into angiotensin II (Ang II) replacing the Val(3)-Tyr(4)-Ile(5) or Tyr(4)-Ile(5) peptide segments. All of the resulting pseudopeptides displayed high AT(2)/AT(1) receptor selectivity and exhibited AT(2) receptor affinity in the low nanomolar range. Molecular modeling was used to investigate whether the compounds binding to the AT(2) receptor could position important structural elements in common areas. A previously described benzodiazepine-based gamma-turn mimetic with high affinity for the AT(2) receptor was also included in the modeling. It was found that the molecules, although being structurally quite different, could adopt the same binding mode/interaction pattern in agreement with the model hypothesis. The pseudopeptides selected for agonist studies were shown to act as AT(2) receptor agonists being able to induce outgrowth of neurite cells, stimulate p42/p44(mapk), and suppress proliferation of PC12 cells.

  DOI：

  10.1021/jm0491492
• 作为产物：
  描述：

  2-氯-3-硝基苄醇 在 sodium chlorite 、 sodium dihydrogenphosphate 、 草酰氯 、 sodium cyanoborohydride 、 溶剂黄146 、 二甲基亚砜 、 1,8-二氮杂双环[5.4.0]十一碳-7-烯 、 三乙胺 、 N,N-二异丙基乙胺 、 N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate 作用下， 以 四氢呋喃 、 甲醇 、 二氯甲烷 、 二甲基亚砜 、 叔丁醇 为溶剂， 反应 28.25h， 生成 (2S,3S)-2-[(2S)-2-(4-tert-butoxybenzyl)-9-nitro-3-oxo-1,2,3,5-tetrahydrobenzo[1,4]diazepin-4-yl]-3-metylpentanoic acid
  参考文献：
  名称：

  New Selective AT₂ Receptor Ligands Encompassing a γ-Turn Mimetic Replacing the Amino Acid Residues 4−5 of Angiotensin II Act as Agonists

  摘要：

  New benzodiazepine-based gamma-turn mimetics with one or two amino acid side chains were synthesized. The gamma-turn mimetics were incorporated into angiotensin II (Ang II) replacing the Val(3)-Tyr(4)-Ile(5) or Tyr(4)-Ile(5) peptide segments. All of the resulting pseudopeptides displayed high AT(2)/AT(1) receptor selectivity and exhibited AT(2) receptor affinity in the low nanomolar range. Molecular modeling was used to investigate whether the compounds binding to the AT(2) receptor could position important structural elements in common areas. A previously described benzodiazepine-based gamma-turn mimetic with high affinity for the AT(2) receptor was also included in the modeling. It was found that the molecules, although being structurally quite different, could adopt the same binding mode/interaction pattern in agreement with the model hypothesis. The pseudopeptides selected for agonist studies were shown to act as AT(2) receptor agonists being able to induce outgrowth of neurite cells, stimulate p42/p44(mapk), and suppress proliferation of PC12 cells.

  DOI：

  10.1021/jm0491492

文献信息

• New Selective AT₂ Receptor Ligands Encompassing a γ-Turn Mimetic Replacing the Amino Acid Residues 4−5 of Angiotensin II Act as Agonists
  作者：Ulrika Rosenström、Christian Sköld、Bianca Plouffe、Hélène Beaudry、Gunnar Lindeberg、Milad Botros、Fred Nyberg、Gunter Wolf、Anders Karlén、Nicole Gallo-Payet、Anders Hallberg

  DOI：10.1021/jm0491492

  日期：2005.6.1

  New benzodiazepine-based gamma-turn mimetics with one or two amino acid side chains were synthesized. The gamma-turn mimetics were incorporated into angiotensin II (Ang II) replacing the Val(3)-Tyr(4)-Ile(5) or Tyr(4)-Ile(5) peptide segments. All of the resulting pseudopeptides displayed high AT(2)/AT(1) receptor selectivity and exhibited AT(2) receptor affinity in the low nanomolar range. Molecular modeling was used to investigate whether the compounds binding to the AT(2) receptor could position important structural elements in common areas. A previously described benzodiazepine-based gamma-turn mimetic with high affinity for the AT(2) receptor was also included in the modeling. It was found that the molecules, although being structurally quite different, could adopt the same binding mode/interaction pattern in agreement with the model hypothesis. The pseudopeptides selected for agonist studies were shown to act as AT(2) receptor agonists being able to induce outgrowth of neurite cells, stimulate p42/p44(mapk), and suppress proliferation of PC12 cells.